Cinctive Capital Management LP

Position in RVMD — Revolution Medicines, Inc.

CIK 1787258 New York, NY

Position in RVMD

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$9,127,593

+$5,731,716 QoQ

Shares Held

93,857

+120.1% QoQ

Ownership

0.044%

of shares outstanding

% of Portfolio

0.61%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Cinctive Capital Management LP holds $185,949,026 across 51 Biotechnology names. RVMD ranks #6 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	73,063	$11,947,261
2	BBIO	BridgeBio Pharma, Inc.	145,728	$10,821,761
3	NTHI	Neonc Technologies Holdings, Inc.	1,425,526	$9,992,937
4	DAWN	Day One Biopharmaceuticals, Inc.	450,000	$9,648,000
5	ACLX	Arcellx, Inc.	80,000	$9,185,600
6	RVMD	Revolution Medicines, Inc. This page	93,857	$9,127,593
7	SRRK	Scholar Rock Holding Corp	172,535	$8,481,820
8	MDGL	Madrigal Pharmaceuticals, Inc.	15,326	$8,022,701

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$9,127,593	93,857	+120.1%	Shares	Sole	2026-05-15
2025-12-31	$3,395,877	42,635	+275.9%	Shares	Sole	2026-02-17
2025-03-31	$401,088	11,343	-67.4%	Shares	Sole	2025-05-15
2024-12-31	$1,521,714	34,790	-34.8%	Shares	Sole	2025-02-12
2024-09-30	$2,419,921	53,361	+132.7%	Shares	Sole	2024-11-14
2024-06-30	$889,952	22,931	-39.9%	Shares	Sole	2024-08-14
2024-03-31	$1,229,929	38,161	-41.4%	Shares	Sole	2024-05-15
2023-12-31	$1,867,297	65,108	—	Shares	Sole	2024-02-14
No filing history on record for this holder in this stock.